Patients Perspective in Plasma Products (Focus on Hemophilia)
Journal Title: Iranian Journal of Blood and Cancer - Year 2011, Vol 3, Issue 3
Abstract
Effective treatment of inherited bleeding disorders has become available from plasma in the last 50 years. Plasma-derived medicinal products are used in Iran in a wide variety of clinical problems. Some of these products are manufactured by Iranian voluntary donor plasma in contract to Euro-pean pharmaceutical company. The safe preparation of plasma products is important; including screening blood donors, testing plasma for infectious pathogens. A perspective of the World Federation of Hemophilia (WFH) is to increase worldwide supply of safe affordable factor replacement therapy.
Authors and Affiliations
Mohammad Faranoush
Co-inheritance of α-and β-thalassemia: challenges in prenatal diagnosis of thalassemia
Background: The double heterozygous state of α/β thalassemia may alter the hematological indices and modify the phonotype. In addion, definite characterizaon of co-inheritance of α- and β-thalassemia heterozygous carri...
Knowledge of Breast Cancer Risk Factors among a Cohort of Nurses in Iran
Background: Improving the knowledge of healthcare providers towards different aspects of breast cancer leads to appropriate management and screening of disease. This study aimed to investigate the knowledge of breast can...
The 10th National Congress of IPHOS - Neonatal Hematology
This article has no abstract.
The Prevalence of Tumor Lysis Syndrome in Children and Adolescents with Cancer in Hamedan Province, Iran
Background: Tumor lysis syndrome caused by widespread tumor cell damage may lead to electrolyte imbalances and express as metabolic disturbance causing clinical abnormalities. Patients and Methods: All patients younger t...
HTLV-1 Infection as a Serious Health Issue among Iranian Multi-Transfused Patients: Evidence from a Systematic Review and Meta-Analysis
Background: A high prevalence of human T-cell lymphotropic virus type 1 (HTLV-1) infection among general population in the northeast of Iran has been reported. Multi-transfused patients are known as ‘at-risk’ group for t...